Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

Notice of Intent to Publish a Funding Opportunity Announcement for Morris K. Udall Discovery Centers without Walls (DCWoW) for Parkinson's Disease Research (RM1 - Clinical Trial Optional)

Active
Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The National Institute of Neurological Disorders and Stroke (NINDS) intends to publish a Notice of Funding Opportunity to establish Morris K. Udall Discovery Centers without Walls (DCWoW) for Parkinson's Disease Research. This initiative aims to advance biomedical discovery and identify the causes of Parkinson's disease and related synucleinopathies through an integrated team science approach. The program focuses on addressing the chronic, progressive nature of the disorder, including both motor and non-motor symptoms, to move beyond current limited pharmacological and surgical treatments toward a definitive cure. This forecast serves as a notification for investigators with expertise in the field to develop collaborations and innovative projects. While the initiative extends the existing Udall Centers program into new directions to enable research not possible through other grant mechanisms, applications are not being solicited at this time. The effort is managed by the National Institutes of Health under the Department of Health and Human Services.

General Info

NIH seeks transformative, team-based Parkinson’s research centers without walls to uncover causes and advance cures.

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health
Contacts1 person available
OfficeUSA
Office AddressUSA
Contacts
Beth Anne Sieber PhD National Institute of Neurological Disorders and Stroke (NINDS

Full Description

Show more

The National Institute of Neurological Disorders and Stroke (NINDS) intends to promote team science research to discover the causes of Parkinson's Disease by publishing a Notice of Funding Opportunity (NOFO) to solicit applications for Morris K. Udall Discovery Centers without Walls (DCWoW) for Parkinson's Disease Research.Parkinson’s disease (PD) is a chronic, progressive movement disorder that affects the lives of at least half a million people across the United States (US), as well as having significant impact on the relatives and friends who care for them. The average onset of characteristic motor symptoms, which are initially subtle and increasingly impact purposeful movement, most often occurs in the sixth decade of life; onset at much younger ages is also possible. Persons with PD also experience a broad range of non-motor symptoms including autonomic dysfunction (e.g. constipation, urinary incontinence, orthostatic hypotension, sexual dysfunction), sleep disturbances, pain, changes in mood, and cognitive dysfunction potentially leading to dementia. Available pharmacological and surgical treatments provide limited relief from some motor symptoms but fail to address non-motor symptoms or attenuate the ultimate progression of the disease. A clear cause and definitive cure have remained elusive despite important biomedical research advances, such as the identification of environmental and genetic risk factors. As our population ages, the number of persons with PD is projected to increase significantly; mounting evidence suggests that global burden, including disability and mortality due to PD, are increasing at a more rapid rate compared with other neurological diseases.In recognition of the impact of PD on our society, and to advance innovative research into the causes of PD, this initiative will promote biomedical discovery through an integrated team science approach. Established in 1998 via the Morris K. Udall Parkinson's Disease Research Act (P.L. 105-78), the NINDS Udall Centers of Excellence for PD Research program is a central component of NINDS-supported PD research. This new initiative will extend the Udall Centers program in novel directions and enable applicants to focus on discovery research not possible via other grant mechanisms. This Notice encourages investigators with expertise, insights, and innovative approaches in the area of Parkinson's disease and related synucleinopathies to begin to consider applying for this new NOFO. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. Applications are not being solicited at this time.

Similar Contracts

Same NAICS industry code

NAICS: 541715
New
Federal
ACC-DTA Commercial Solutions Opening (CSO)
Solicitation # W912CH-26-S-0001
The Army Contracting Command – Detroit Arsenal (ACC-DTA) Commercial Solutions Opening (CSO), solicitation W912CH-26-S-0001, serves as a rapid-acquisition gateway to transition cutting-edge commercial technologies into active defense programs. This vehicle supports a diverse customer base, including the Intelligence and Security Command (INSCOM) and six Portfolio Acquisition Executives, focusing on the development, integration, and sustainment of ground vehicle systems to enhance Army modernization and readiness. The CSO utilizes a streamlined, merit-based, multi-phased evaluation process consisting of solution briefs, presentations, and commercial solution proposals. Awards may be issued through 2028 as FAR Part 12 contracts or non-FAR agreements, such as Other Transaction Authority (OTA) and Cooperative Agreements. The solicitation is organized around various Areas of Interest (AoI) that address critical military needs. Key initiatives include the FALCONS prototype effort for long-range reconnaissance sensors with funding ceilings between 24 million and 30 million dollars, the TIGER Readiness and Hackathon programs for Abrams Main Battle Tank engine supply chain resilience, and requirements for Counter-Unmanned Aircraft Systems (C-UAS) detection, Mobile Camouflage Systems, and Light Tactical Trailer Heavy Chassis. Technical evaluations focus on mission viability and prototype execution, while price proposals are assessed for affordability. To be eligible for award, companies must be registered in the System for Award Management (SAM) with a Unique Entity ID and comply with the Buy American Act and Specialty Metals clauses.
W6QK Acc- Dta

POSTED

about 12 hours ago

DEADLINE

in about 2 years
View Details
NAICS: 541715
New
Federal
BAA DEVCOM AC Emerging Technologies
Solicitation # W15QKN-26-S-1AZR
The U.S. Army Combat Capabilities Development Command Armaments Center is soliciting research proposals and white papers for new and innovative technologies related to emerging weapons, munitions systems, and soldier lethality. Issued under FAR 6.102(d)(2), this Broad Agency Announcement is a continuously open solicitation effective from March 5, 2026, through March 4, 2031. The program seeks to advance the state of the art through collaborations with industry and academia, with a particular interest in scientific study and experimentation that fills technology needs across the product life cycle, including improvements in armament packaging, ammunition logistics, and micro-system architecture. The submission process is a two-stage effort beginning with a white paper, which is limited to six pages plus a cover page and biographical sketches. Offerors whose white papers are favorably evaluated may be invited to submit a full research proposal. The government prefers proposals covering a three-year period of performance with incremental funding. Awards are based on a competitive selection process evaluating overall scientific and technical merit, potential contributions to the Army mission, offeror capabilities, personnel qualifications, past performance, and proposed price. All submissions must be unclassified and adhere to strict formatting guidelines, including 12-point Times New Roman font for narrative text.
W6QK Acc-Ri-Picatinny

POSTED

about 12 hours ago

DEADLINE

in over 4 years
View Details
NAICS: 541715
New
Federal
Common Autonomous Multi-Domain Launcher (CAML)-Lite Prototype Effort
Solicitation # W50RAJ27CAML_LITE
The Common Autonomous Multi-Domain Launcher (CAML)-Lite Prototype Effort is a competitive procurement conducted under 10 U.S.C. section 4022 for the development of a mobile, optionally manned, autonomous launcher designed to increase survivability and reduce manned support for cross-domain fires. Managed by the Department of Defense, this effort utilizes Other Transaction Agreements (OTAs) and follows a two-phase structure. Phase 1 focuses on a government-sponsored prototype demonstration at Talisman Sabre 2027 in August 2027, with options for the government to acquire additional prototype units, new equipment training, and contractor logistics support. Phase 2 involves maturing selected solutions into a production-representative configuration integrated into a common CAML architecture. The procurement process begins with a Request for Solutions Brief to identify meritorious respondents, who will then be invited to submit a Request for Prototype Proposal. Key technical requirements include the use of a Modular Open Systems Approach (MOSA) to ensure interchangeable modules and common interfaces. Performers are required to assume full responsibility for international logistics and compliance for the Phase 1 demonstration and must adhere to minimum Right to Repair requirements as a condition of award. Selection for Phase 1 is based on the feasibility of the maturation path and the technical soundness of the approach, while subsequent option exercises will prioritize speed of delivery, technical performance, property rights, and the right to repair. Phase 1 OTA awards are expected by December 18, 2026, with a firm-fixed-price payment structure split between award and demonstration completion.
W6DV Peo M & S Redstone

POSTED

1 day ago

DEADLINE

in about 21 hours
View Details
NAICS: 541715
New
Federal
Fast Assessment of Solutions, Therapeutics, Pharmaceuticals, and SupplieS (FASTPASS) Innovative Solutions Opening
Solicitation # ARPA-H-SOL-26-160
The Fast Assessment of Solutions, Therapeutics, Pharmaceuticals, and Supplies (FASTPASS) program, under solicitation ARPA-H-SOL-26-160, is an initiative by the Advanced Research Projects Agency for Health (ARPA-H) to develop a near real-time, non-destructive, AI-enabled screening system. The goal is to identify contamination, adulteration, and quality defects in pharmaceutical products through their packaging at ports of entry and other supply-chain nodes using multi-modal sensing and data fusion. This 54-month program is structured into three 18-month phases, culminating in a fieldable platform with validated training materials and integrated documentation capabilities. This procurement is conducted as a multiple-award Other Transaction (OT) Agreement rather than a standard federal contract, meaning it is governed by specific OT articles instead of the Federal Acquisition Regulation. Awards are based on the most advantageous proposals, with primary evaluation factors including innovation, soundness, execution planning, risk management, and team expertise. Payments are fixed and triggered by the successful completion of milestones, managed through the Payment Management System. Proposers must be registered in SAM.gov and provide detailed technical and cost proposals, including a milestone payment schedule and research security disclosures. Amendment 01 specifically updated the cost proposal narrative model and workbook to correct typographical errors and rename appendices.
Advanced Research Projects Agency For Health (arpa-H)

POSTED

1 day ago

DEADLINE

in 19 days
View Details

More opportunities from Department Of Health And Human Services → National Institutes Of Health

Same awarding agency

NAICS: 541715
New
Grant
Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource-Constrained Settings--Implementation Science Network (PATC3H-IN)The Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings Implementation Science Network (PATC3H-IN) is a National Institutes of Health initiative focused on conducting implementation science research to combat adolescent HIV. By developing and testing scalable, low-resource care delivery models in low- and middle-income countries, the network aims to generate robust evidence on HIV incidence, prevention uptake, and viral suppression. These international studies leverage large adolescent populations and innovative, cost-effective service delivery methods to create practice-ready strategies that can be adapted for marginalized and high-burden populations within the United States. The program addresses critical gaps in the U.S. healthcare system where adolescents face similar barriers to care as those in resource-constrained global settings, including poverty, stigma, and fragmented services. Comprising Clinical Research Centers and a Data and Coordinating Center, PATC3H-IN supports the goals of the Ending the HIV Epidemic in the U.S. initiative by accelerating the translation of resilient and cost-conscious care models into domestic practice. This effort is authorized under the Eunice Kennedy Shriver National Institute of Child Health and Human Development to improve overall care outcomes and prevent new HIV acquisitions among at-risk youth.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

3 days ago

DEADLINE

N/A
View Details
NAICS: 541715
Grant
Continuation of the Exceptional Longevity Data Management and Coordinating Center (EL DMCC) (U24 Clinical Trial Not Allowed)The National Institute on Aging intends to issue a single U24 cooperative agreement award to support the continued operation and expansion of the Exceptional Longevity Data Management and Coordinating Center. Serving as the central hub for human longevity translational research, the center integrates deeply phenotyped cohorts and multi-omics datasets to enable cross-cohort analyses and collaborative research. Key responsibilities include data harmonization, the implementation of common data standards, and the management of the ELITE Portal, which provides the research community with secure access to analytical tools and cloud-based computational workspaces. The upcoming funding opportunity will require the Coordinating Center to expand its capabilities in artificial intelligence, machine learning, and the integration of diverse datasets across different species. Future objectives include the development of curated target knowledgebases for therapeutic targets, the enhancement of portal interoperability according to FAIR data principles, and the strengthening of community engagement through specialized training and workshops. This notice serves as a forecast to allow potential applicants to establish collaborations before the official solicitation is released.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

29 days ago

DEADLINE

N/A
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS